Drug Database
Back to search

France· FR:68884833

NICOBION 500 mg, comprimé pelliculé

A nicotinamide product containing nicotinamide, registered in France by TEOFARMA. The same ATC class is registered in 8 of our 19 countries.

ATC A11HA01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedNICOBION 500 mg, comprimé pelliculéATCA11HA01REGISTER NO.FR:68884833PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nicotinamideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nicotinamide is registered in 8 of 19 countries.

Countries holding a registration under ATC A11HA01 (nicotinamide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose
Search nicotinamide products by name

Nicotinamide · ATC A11HA01

8 / 19 countries

  • Belgiumprice
  • Franceprice
  • Germany
  • Japan
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
NICOTINAMIDE
Manufacturer
TEOFARMA
Country
France (FR)
ATC code
A11HA01
ATC class
Nicotinamide
Defined daily dose
0.15 g, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400930726617
    1 plaquette(s) polyamide aluminium PVC-Aluminium de 30 comprimé(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

83 interactions on record for nicotinamide.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nicotinamide against other medicinesHow interaction checks work

Nicotinamide · interactions on record

83 records

  • 7 severe
  • 75 moderate
  • 1 minor

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nicotinamide in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nicotinamide products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Belgium · Nicotinamide Sterop
  • Germany · Nicotinamid Axicur
  • United Kingdom (Northern Ireland) · Freederm, Freederm Treatment
  • Ireland · Nicam
  • Italy · Nicotinamide Idi
  • Poland · Vitaminum Pp Polfarmex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/41bbbca0-6b4d-4812-86ac-1ef39c5bd9ed
GET /v1/drugs/41bbbca0-6b4d-4812-86ac-1ef39c5bd9ed?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68884833",
  "date_amm": "1997-07-07",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "NICOTINAMIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about nicotinamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console